A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Jamy, Omer [1 ]
Innis-Shelton, Racquel [2 ]
Bal, Susan [3 ]
Salzman, Donna [4 ,5 ]
Costa, Luciano J. [4 ,5 ]
di Stasi, Antonio [6 ]
Lamb, Lawrence [2 ]
Mineishi, Shin [7 ]
Saad, Ayman [4 ,5 ]
机构：
[1] Univ Alabama Birmingham Hosp, Birmingham, AL USA
[2] Univ Alabama Birmingham, Med, Birmingham, AL USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
[4] Univ Alabama Birmingham Hosp, Bone Marrow Transplantat & Cell Therapy Program, Birmingham, AL USA
[5] Univ Alabama Birmingham Hosp, Dept Med, Div Hematol Oncol, Birmingham, AL USA
[6] Univ ofAlabama, Stem Cell Transplantat & Cellular Therapy, Birmingham, AL USA
[7] Penn State Hershey Med Ctr, Blood & Marrow Transplantat Program, Hershey, PA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
280
引用
收藏
页码：S190 / S191
页数：2
相关论文
共 50 条
  • [31] Post-Transplant Cyclophosphamide after Matched Sibling and Unrelated Donor Hematopoietic Stem Cell Transplantation in Pediatric Patients with Acute Myeloid Leukemia
    Sheikh, Irtiza N.
    Alqahtani, Shaikha
    Ragoonanan, Dristhi
    Tewari, Priti
    Petropoulos, Demetrios
    Mahadeo, Kris M.
    Popat, Uday
    Shpall, Elizabeth J.
    Khazal, Sajad
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (15)
  • [32] Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prophylaxis in Alternative Donor Stem Cell Transplantation: Immune Reconstitution and Infection Risk
    Nagler, Arnon
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (11): : 883 - 884
  • [33] Post-transplant cyclophosphamide as graft-versus-host disease prophylaxis in HLA matched sibling donor stem cell transplantation for patients with acute leukemia.
    Elshamy, Alaa Nabil
    Abdelmohsen, Essam Ali
    Denewer, Mai
    Mabed, Mohamed Nasr
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [34] Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Carter, Michael
    Taniguchi, Michiko
    Yang, Dongyun
    Arslan, Shukaib
    Shouse, Geoffrey
    Ali, Haris
    Karras, Nicole
    Gendzekhadze, Ketevan
    Al Malki, Monzr M.
    BONE MARROW TRANSPLANTATION, 2022, 57 (01) : 134 - 136
  • [35] Donor-specific HLA antibodies associate with chronic graft-versus-host disease in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
    Michael Carter
    Michiko Taniguchi
    Dongyun Yang
    Shukaib Arslan
    Geoffrey Shouse
    Haris Ali
    Nicole Karras
    Ketevan Gendzekhadze
    Monzr M. Al Malki
    Bone Marrow Transplantation, 2022, 57 : 134 - 136
  • [36] Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Sarita Rani Jaiswal
    Aditi Chakrabarti
    Sumita Chatterjee
    Sneh Bhargava
    Kunal Ray
    Suparno Chakrabarti
    International Journal of Hematology, 2016, 103 : 234 - 242
  • [37] Hemophagocytic syndrome following haploidentical peripheral blood stem cell transplantation with post-transplant cyclophosphamide
    Jaiswal, Sarita Rani
    Chakrabarti, Aditi
    Chatterjee, Sumita
    Bhargava, Sneh
    Ray, Kunal
    Chakrabarti, Suparno
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2016, 103 (02) : 234 - 242
  • [38] Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
    Moiseev, Ivan S.
    Pirogova, Olga V.
    Alyanski, Alexandr L.
    Babenko, Elena V.
    Gindina, Tatyana L.
    Darskaya, Elena I.
    Slesarchuk, Olga A.
    Bondarenko, Sergey N.
    Afanasyev, Boris V.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (06) : 1037 - 1042
  • [39] Results of a Two-Arm Phase II Clinical Trial Using Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease in Haploidentical and Mismatched Unrelated Donors Hematopoietic Stem-Cell Transplantation
    Gaballa, Sameh
    Ge, Isabell
    El Fakih, Riad O.
    Brammer, Jonathan E.
    Wang, Sa A.
    Lee, Dean A.
    Petropoulos, Demetrios
    Cao, Kai
    Rondon, Gabriela
    Chen, Julianne
    Hammerstrom, Aimee E.
    Al-Atrash, Gheath
    Korbling, Martin
    Oran, Betul
    Kebriaei, Partow
    Ahmed, Sairah
    Shah, Nina
    Rezvani, Katayoun
    Marin, David
    Bashir, Qaiser
    Alousi, Amin M.
    Nieto, Yago
    Qazilbash, Muzaffar H.
    Hosing, Chitra M.
    Popat, Uday R.
    Shpall, Elizabeth J.
    Khouri, Issa F.
    Champlin, Richard E.
    Ciurea, Stefan O.
    BLOOD, 2015, 126 (23)
  • [40] Short Course of Post-Transplant Cyclophosphamide and Bortezomib for the Prevention of Graft-Versus-Host-Disease after Matched Related or Unrelated Donor Blood or Marrow Transplant
    Al-Homsi, A. Samer
    Roy, Tara S.
    Cole, Kelli
    Bogema, Marlee
    Duffner, Ulrich
    Williams, Stephanie F.
    Mageed, Aly A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S322 - S322
12345